The Management of Iron Chelation Therapy: Preliminary Data from a National Registry of Thalassaemic Patients

Table 3

Percentage of use of the different chelating agents in the centres participating to the study and having in care both paediatric and adult patients.

Iron chelation treatment	Median (%)	Min–Max (%)
DFO	24.5	8.1–70.8
DFP	14.9	3.8–49.5
DFX	28.9	17.0–41.5
Combined therapy	25.4	0.0–34.2